Cancer Care in War Zones: Ethical Considerations and Global Responsibility

Abstract

Cancer care is vital to international health, yet those in war zones have a difficult time receiving life-saving treatment. The devastation of health centers, lack of medications, and deaths of trained medical staff make it extremely difficult for those fighting cancer. This article discusses the difficulties experienced by cancer patients in conflict areas. It addresses the disruption of healthcare, the lack of specialized care, and the increasing mortality rates resulting from delayed treatment. It also touches on the moral obligation of the global medical community and humanitarian organizations to help alleviate this crisis. This study uses Syrian, Ukrainian, and Iraqi case studies, as well as global statistics of cancer fatalities through delayed treatment. It concludes that there is an urgent need for impactful measures to be implemented, including mobile cancer treatment centers, telemedicine, and diplomatic efforts to allow humanitarian aid. The paper concludes that global cooperation is necessary to assist cancer patients in conflict areas and uphold the moral principles of medical care.

Introduction 

Cancer is one of the leading causes of mortality worldwide, with millions of individuals in need of ongoing medical care. However, in war-torn areas, where health systems deteriorate under the pressure of conflict, cancer patients have to face an even more daunting battle. Medics immediately treat trauma injuries, but they simply do not provide chronic illnesses, like cancer, with the attention that they require. As such, patients have little or no access to essential therapies. The devastation of medical institutions, the scarcity of oncology professionals, and the interruption of medical supply chains increase the morbidity and mortality of cancer patients in conflict zones. 

The moral considerations involved in managing cancer treatment in conflict-zone areas represent the ethical obligations that lie on the global healthcare community, humanitarian agencies, and global leaders. In a situation of conflict, the primary objective of medical intervention is to provide emergency treatment to the victims. However, it is important to mention that patients with non-communicable diseases like cancer still need ongoing medical care. This study examines the numerous challenges that cancer patients experience in conflict areas, examines the ethical considerations of their treatment, and offers possible solutions to the current crisis. 

The Challenges of Cancer Care in Conflict Zones 

The Destruction of Healthcare Infrastructure 

The biggest drawback of cancer care within war zones is the physical destruction of hospitals. Clinics, specialized cancer treatment units, and hospitals are typically destroyed or commandeered for use as military facilities, preventing people from having access to vital health care (Atassi et al., 2022). The destruction of facilities also leads to the loss of crucial medical records, complicating the process of resuming treatment for displaced patients. In Syria, for example, ongoing conflict has destroyed large oncology centers, resulting in patients traveling to neighboring nations for treatment or forgoing it (Selmani et al., 2024). 

Shortages of Medical Supplies and Medication

Access to chemotherapy drugs, radiation therapy equipment, and diagnostic machines is severely curtailed in conflict areas. Sanctions, supply disruptions, and attacks on medical convoys hinder lifesaving medications from reaching patients in need (Ahmed, 2023). Iraqi cancer treatment facilities have reported drastic shortages of essential chemotherapy drugs over the last few years, leading to increased mortality among patients with aggressive forms of cancer (Skelton et al., 2023). Moreover, shortages of pain medications have also led to innumerable amounts of suffering among numerous patients, deteriorating their health and reducing their quality of life.

Displacement and Lack of Specialized Medical Personnel

War tends to drive experienced healthcare professionals out of war zones, creating a severe shortage of oncologists, radiologists, and surgeons. The lack of specialized personnel exacerbates delays in treatment and lowers the quality of cancer care. Hanna et al. (2020) point out that even a delay of four weeks in cancer treatment can significantly contribute to mortality. In conflict zones, waiting lists of months and even years cause treatment to become futile. There is also an absence of specialized professionals, such that general practitioners and nurses with possibly no training in oncology have to manage complex cases with minimal resources.

The Ethical Responsibility of the International Medical Community 

Medical Neutrality and the Protection of Healthcare Services

Medical neutrality is a fundamental ethical requirement that protects health professionals and facilities from violence during armed conflict. In fact, attacking hospitals and medical convoys in most conflict-affected regions violates international humanitarian law (Selmani et al., 2024). The global community needs to uphold the protection of health facilities and ensure they continue to operate in conflict-torn regions. Enforcing stronger laws and stiffer punishments for attacks on medical institutions might deter future violations. 

Ensuring Equitable Access to Cancer Treatment 

Access to cancer treatment cannot be determined by location. Ahmed (2023) insists that oncology services must rank highly in global organizations' humanitarian relief programs and allocation of resources in war zones. Humanitarian relief offers some form of cancer care to patients, but it’s still hard to find and access. Incorporating cancer care into emergency medical relief would bridge the care gap for affected communities by healthcare professionals. Financial assistance and collaborations with pharmaceutical firms may also enable chemotherapy and radiotherapy equipment donations to crisis-stricken areas. 

Strengthening International Collaboration and Policy Initiatives 

Conquering the obstacles of cancer treatment in conflict areas demands cooperative action from international bodies. International organizations such as the World Health Organization (WHO), the International Atomic Energy Agency (IAEA), and global humanitarian non-governmental organizations (NGOs) must collaborate to develop policies that offer equal medical care for cancer patients impacted by conflict zones. In humanitarian crises, having global task forces for oncology treatment would make the process easier by unifying medicine, making cancer drugs safer to transport, and sending mobile oncology teams to help out (Skelton et al., 2023). Further, advocating for cancer therapy to be explicitly included in international humanitarian budgets would make long-term assistance a possibility. By developing global cooperation, policymakers can improve healthcare systems in war-torn regions to become more resilient and reduce mortality rates from delayed cancer treatment. 

Long-Term Impact of War on Cancer Care and Survivorship 

Rebuilding Healthcare Systems Post-Conflict 

War has prolonged catastrophic impacts on healthcare infrastructure, and even after conflicts end, the reconstitution of oncology services is a significant endeavor. Rebuilding hospitals and treatment centers is necessary, and medical supply chains must be re-established to gain stable access to chemotherapy, radiation therapy, and palliative care (Ahmed, 2023). Hiring and training oncologists, radiologists, and surgeons are also essential since the majority of the specialists depart conflict areas, and there is a dire lack of cancer care (Skelton et al., 2023). Without long-term investment, post-conflict regions can continue to have a lack of oncology services, which can exacerbate disparities in cancer outcomes. 

Psychosocial and Economic Burdens on Cancer Survivors 

Cancer survivors and patients who live in conflict areas tend to experience long-term psychological trauma, on top of displacement stress and economic insecurity. The majority of survivors develop post-traumatic stress disorder (PTSD) and depression that impair their quality of life and recovery negatively (Atassi et al., 2022). Socioeconomic challenges in the form of war-induced unemployment also impede survivors from seeking ongoing care, medication, and follow-up therapy. Humanitarian groups and policymakers should put in place post-war rehabilitation schemes that treat both the medical and psychosocial requirements of cancer survivors, securing their long-term health. 

Environmental and Public Health Consequences of War on Cancer Rates

Besides the direct damage to the health system, the conflicts also impose long-term environmental effects that could increase the rates of cancer in the population within affected regions. The use of chemical weapons, radiation due to bombing, and water and land contamination with harmful substances contribute to a higher rate of cancer in post-war areas (Hanna et al., 2020). For instance, it has been proven that there is an increased prevalence of leukemia and other cancers in environments saturated with depleted uranium explosives (Ahmed, 2023). In addition, dismantling industrial plants and military activities can release cancer-causing pollutants into the atmosphere and impact whole communities for generations. To reduce these risks, countries should collaborate to assess environmental damage, monitor people's health over time, and initiate cancer screening programs in areas recently affected by war to mitigate the effects of toxic exposure during the conflict. 

Solutions and Strategies for Improving Cancer Care in War Zones 

Mobile Oncology Units and Telemedicine 

Mobile oncology units have the potential to provide essential cancer care to affected patients. The units, equipped with chemotherapy, diagnostic equipment, and palliative care supplies, can reach displaced individuals and residents in areas without health facilities (Skelton et al., 2023). Some of the largest humanitarian crises have effectively employed mobile units, providing life-saving interventions where hospitals may not be available or are inaccessible. In addition, telemedicine can also facilitate remote consultations, with oncologists outside war zones offering advice on treatment and monitoring patients' progress (Atassi et al., 2022). Through the application of telecommunication technologies, even individuals in the remotest or war-torn regions can receive expert advice. 

Diplomatic and Humanitarian Efforts

Humanitarian access to conflict zones requires diplomatic negotiation and international diplomacy. Medical convoys need access to cancer treatment centers granted through ceasefires lobbied for by the World Health Organization (WHO) and non-governmental organizations (NGOs). Diplomatic missions to Ukraine have recently opened temporary humanitarian access to cancer treatment centers, demonstrating that global cooperation can work (Selmani et al., 2024). Humanitarian corridors under international law must be consolidated to ensure uninterrupted oncology services irrespective of the intervention of the belligerents. 

Leveraging Technology for Cancer Care 

Technologies such as artificial intelligence (AI) and big data analysis can be employed to treat and diagnose cancer patients in war-torn regions. According to Ahmed (2023), diagnostic AI technologies have the potential to help oncologists design the best course of treatment and predict what each patient will need based on available resources. Moreover, 3D printing technology is used to produce life-critical medical gear and chemotherapy hardware in conflict-torn nations, with traditional supply networks being disrupted (Selmani et al., 2024). Such technologies support cost-effective solutions for better access to oncology treatments during crisis times. 

Conclusion

The agony of cancer patients in war zones is a pressing worldwide health crisis requiring an immediate solution. The destruction of health infrastructure, loss of medical equipment, and displacement of skilled staff are challenges that become impossible to overcome for those who need life-sustaining therapy. The international medical community, humanitarian non-governmental organizations, and politicians must feel a moral obligation to address this emergency by ensuring equitable access to cancer treatment. Supplemental interventions like mobile oncology clinics, telemedicine, AI-based diagnosis, and diplomatic missions can change the world for cancer patients in war-torn and conflict zones. Understanding and recognizing this moral responsibility, the global community can try to ensure that no cancer patient is deprived of care due to war. Addressing the crisis of cancer care during war is not only an ethical responsibility but also a requirement of upholding humanitarian medical ethics and international health equity.

References

Ahmed, Y. (2023). Enhancing cancer care amid conflict: A proposal for optimizing oncology services during wartime. JCO Global Oncology, 9(9), e2300304. 

https://doi.org/10.1200/GO.23.00304 

Atassi, B., Tse, G., Mkhallalati, H., Debel, J., Jemmo, A., Khalil, M., Alrahal, Y., Almalki, M., Hamadeh, M., Tarakji, A., & Abbara, A. (2022). Cancer diagnoses during active conflict: Experience from a cancer program in northwest Syria. Avicenna Journal of Medicine, 12(4), 157-161. https://doi.org/10.1055/s-0042-1755331 

Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020). Mortality due to cancer treatment delay: Systematic review and meta-analysis. BMJ (Online), 371, m4087-m4087. https://doi.org/10.1136/bmj.m4087 

Selmani, E., Hoxha, I., Tril, O., Khan, O., Hrynkiv, A., Nogueira, L., Pyle, D., & Chamberlin, M. (2024). Fighting cancer in Ukraine at times of war. Hematology/oncology Clinics of North America, 38(1), 77-85. https://doi.org/10.1016/j.hoc.2023.06.001 

Skelton, M., Al-Mash'hadani, A. K., Abdul-Sater, Z., Saleem, M., Alsaad, S., Kahtan, M., Al-Samarai, A. H., Al-Bakir, A. M., & Mula-Hussain, L. (2023). War and oncology: Cancer care in five Iraqi provinces impacted by the ISIL conflict. Frontiers in Oncology, 13, 1151242-1151242. https://doi.org/10.3389/fonc.2023.1151242